Stem Cells International

Stem Cells in Heart Failure


Publishing date
15 Oct 2011
Status
Published
Submission deadline
15 Apr 2011

Lead Editor

1Cardiovascular Research, Institute of Physiology, University of Zürich, Winterthurerstrasse 190, 8057 Zurich, Switzerland

2NIH/NIA/GRC/LCS, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA

3Department of Cardiology, University Hospital, Rämistrasse 100, 8091 Zurich, Switzerland

4Division of Cardiology, Medical University of Silesia, 40-583 Katowice, Poland


Stem Cells in Heart Failure

Description

Heart failure is a leading cause of morbidity and mortality in the developed world. The treatment of heart failure has generally relied on strategies designed to target and limit tissue damage, pathological remodeling, or hemodynamic impairment. Identification of stem cells has however opened new prospects for the development of cell-based regenerative medicine. Indeed, the heart may contain a pool of resident or circulating stem cells, but following injury, these endogenous cells are not sufficiently regenerative to fully repair the damaged myocardium. Alternatively, treatments with exogenous stem cells reduce pathological processes in the damaged heart and improve cardiac tissue regeneration in mice and humans, but it is still a matter of debate whether the delivery of stem cells or stem cell progeny contributes principally to new cardiac tissue formation, to endogenous repair mechanisms, or to the modulation of inflammatory processes.

In this special issue, we encourage the submission of manuscripts describing the role of endogenous and bone marrow-derived stem and progenitor cells in pathophysiological processes following heart injury. We are highly interested in manuscripts that report the clinical and preclinical use of any stem or progenitor cells to treat heart injury. Furthermore, studies on the specific signaling pathways responsible for stem and progenitor cell activation, proliferation and differentiation following the myocardial injury, as well as, reports describing paracrine effects of stem and progenitor cells on the injured myocardium are of major interest. Potential topics include, but are not limited to:

  • Paracrine effect of stem and progenitor cells upon heart injury
  • Association of stem and progenitor cells with myocardial microenvironment
  • Cardioprotective or regenerative capability of ES cells, iPS, endogenous or bone marrow-derived stem, and progenitor cells
  • Contribution of stem and progenitor cells in pathological remodeling
  • Signaling involved in stem and progenitor cell proliferation, migration to the injury sites, and differentiation
  • Heart inflammation and stem and progenitor cells
  • Heart fibrosis and stem and progenitor cells
  • Stem and progenitor cells and microRNAs
  • Immunomodulatory properties of stem and progenitor cells
  • Clinical trials with the use of stem and progenitor cells
  • Cell delivery: implications for clinical trials

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/sci/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2011
  • - Article ID 193918
  • - Editorial

Stem Cells in Heart Failure

Gabriela Kania | Kenneth R. Boheler | ... | Wojciech Wojakowski
  • Special Issue
  • - Volume 2011
  • - Article ID 130970
  • - Research Article

Transcription Factor Lbx1 Expression in Mouse Embryonic Stem Cell-Derived Phenotypes

Stefanie Schmitteckert | Cornelia Ziegler | ... | Alexandra Rolletschek
  • Special Issue
  • - Volume 2011
  • - Article ID 456815
  • - Research Article

An Inducible Expression System of the Calcium-Activated Potassium Channel 4 to Study the Differential Impact on Embryonic Stem Cells

Stefan Liebau | Michael Tischendorf | ... | Alexander Kleger
  • Special Issue
  • - Volume 2011
  • - Article ID 214203
  • - Research Article

Embryonic Stem Cell-Derived Cardiomyocyte Heterogeneity and the Isolation of Immature and Committed Cells for Cardiac Remodeling and Regeneration

Kenneth R. Boheler | Robert N. Joodi | ... | Rong Zhou
  • Special Issue
  • - Volume 2011
  • - Article ID 916180
  • - Review Article

The Impact of Bioactive Lipids on Cardiovascular Development

Alexander Kleger | Stefan Liebau | ... | Thomas Seufferlein
  • Special Issue
  • - Volume 2011
  • - Article ID 679171
  • - Review Article

Advances in Cell Transplantation Therapy for Diseased Myocardium

Outi M. Villet | Antti Siltanen | ... | Ari Harjula
  • Special Issue
  • - Volume 2011
  • - Article ID 310928
  • - Review Article

Stem Cells for Cardiac Repair: Status, Mechanisms, and New Strategies

Ren Mingliang | Zhang Bo | Wang Zhengguo
Stem Cells International
 Journal metrics
Acceptance rate45%
Submission to final decision76 days
Acceptance to publication35 days
CiteScore3.800
Impact Factor3.902
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.